Biotech Business - April 2, 2016
Xintela on Nasdaq
The trading in Xintela AB’s shares commenced last week on Nasdaq First North in Stockholm and the healthcare company is the 11th company to be admitted to trading on Nasdaq’s Nordic markets in 2016. Xintela is a Swedish biomedical company working in the fields of regenerative medicine and cancer, with a particular focus on cartilage damage and […]
Listing - March 15, 2016
AddLife listed on Nasdaq
Yesterday the Swedish company AddLife was listed on Nasdaq Stockholm Main Market. “Today’s listing of AddLife means that we’re now a stand-alone company, a defined Life Science player, in the Nordic countries. It’s our opening-day on the stock exchange but AddLife rests on hundred year of history as a spin-off from Bergman & Beving and […]
Listing - June 19, 2014
Stock market premiere for Bactiguard
On June 19, Bactiguard entered Nasdaq OMX’s main list. The introduction price was in the lower intervall span. Bactiguard has determined the price for the stock market introduction to SEK 38 per B share. The main owners have also decided to reduce the number of shares in the offer which reduces the offer by approximately […]
Listing - June 17, 2014
Acucort raises SEK 4.6 million and starts exit process
The company has recently raised SEK 4.6 million through a rights issue to secure operations during the sales process that has now been initiated. Acucort, a project company within the life science incubator P.U.L.S., has developed an easy soluble film for oral use during acute allergic conditions and is now looking for a buyer. “We […]
